GGrantIndex
Sort

40,608 grants matching prostate cancer

Transgenic Animal Models for Prostate Cancer

$445,093
Robert J Matusik · Vanderbilt University · R01 · FY2007 · CA

Optimizing Treatment Approaches to Lung Cancers Harboring MET Exon 14 mutations

$445,066
Eric Collisson · University Of California, San Francisco · R01 · FY2020 · CA

Molecular mechanisms of DNA double strand break repair by homologous recombination

$445,000
Benjamin M Stinson · Dana-Farber Cancer Inst · R35 · FY2025 · GM

Project 2: Elucidating interactions between genetic and environmental drivers of prostate cancer patient outcomes

$444,977
Matthew R Cooperberg · University Of California, San Francisco · U54 · FY2025 · CA

Role of GPR120 and Macrophages in Dietary Omega-3 Fatty Acid Inhibition of Prostate Cancer

$444,969
William J Aronson · University Of California Los Angeles · R01 · FY2018 · CA

Endocrine Disruptors: Assessment of endocrine disruption activity, mechanism and

$444,890
Subhrangsu S Mandal · University Of Texas Arlington · R15 · FY2010 · ES

Developmental Funds

$444,880
Caryn Lerman · University Of Southern California · P30 · FY2022 · CA

Carbohydrate Antigenic Biomarkers for Epithelial Cancers

$444,838
Mark I Greene · University Of Pennsylvania · U01 · FY2016 · CA

Development of statistical genetics methodology

$444,812
Joan E. Bailey-Wilson · National Human Genome Research Institute · ZIA · FY2012 · HG

Ultrasound Molecular Imaging to Assess Therapeutic Response

$444,786
Mark Andrew Borden · University Of Colorado · R01 · FY2015 · CA

Prospective Study of Human Oral Microbiome and Pancreatic Cancer Risk

$444,726
Jiyoung Ahn · New York University School Of Medicine · R01 · FY2014 · CA

Personalized Risk-AdaptIve Surveillance strategies in cancEr -- PRAISE

$444,555
Aasthaa Bansal · University Of Washington · R37 · FY2021 · CA

Novel Therapeutic Strategies to Co-Target Undifferentiated Prostate Cancer (PCa) Stem Cells and Bulk PCa Cells

$444,510
Dean G Tang · Roswell Park Cancer Institute Corp · R01 · FY2019 · CA

INTERVENTION DEVELOPMENT AND MEASUREMENT

$444,487
Suzanne M Miller · University Of Colorado Denver · P01 · FY2009 · CA

Extraction of Symptom Burden from Clinical Narratives of Cancer Patients using Natural Language Processing

$444,461
Meliha Yetisgen · University Of Washington · R21 · FY2021 · CA

Oncogenic Met Signaling in Urologic Malignancies

$444,424
Donald Bottaro · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA

FAMILY HOME CARE FOR CANCER--A COMMUNITY BASED MODEL

$444,395
Michigan State University · R01 · FY2001 · CA

Targeted Molecular Agents for Photoacoustic Imaging of Prostate Cancer

$444,367
Hans F. Schmitthenner · Rochester Institute Of Technology · R15 · FY2014 · CA

PI3K/PTEN/Akt signaling and the genesis of cancer

$444,339
Nissim Hay · University Of Illinois At Chicago · R01 · FY2024 · CA

A novel strategy to overcome drug resistance in cancer

$444,318
Aimee L Edinger · University Of California-Irvine · R01 · FY2024 · CA

The microtubule cytoskeleton as a novel target for cavernous nerve regeneration after prostatectomy

$444,306
Kelvin P Davies · Albert Einstein College Of Medicine, Inc · R01 · FY2018 · DK

Regulation of NF-kapaB and IKK by proinflammatory stimuli

$444,208
Michael Karin · University Of California, San Diego · R01 · FY2010 · AI

Multifunctional immunoPET tracers for pancreatic and prostate cancer

$444,176
Anna M Wu · University Of California Los Angeles · R01 · FY2016 · CA

Multifunctional immunoPET tracers for pancreatic and prostate cancer

$444,176
Anna M Wu · University Of California Los Angeles · R01 · FY2017 · CA

Tailored Approaches to Stroke Health Education

$444,130
Olajide Williams · New York University School Of Medicine · U54 · FY2012 · NS